Assessing the Safety and Tolerability of CSL730 in Healthy Caucasian and Japanese Adults

NCT03375606 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
26
Enrollment
INDUSTRY
Sponsor class

Stopped The Sponsor decided to terminate this study in favor of development of subcutaneous administration.

Conditions

Interventions

Sponsor

CSL Behring